Company intelligence / Profile preview
Biostar Pharmaceuticals
Beijing, Chinabiostar-pharm.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Utidelone injectable, the lead product, was approved by China's NMPA in March 2021 for metastatic breast cancer after demonstrating superior efficacy over standard regimens and good safety profile in Phase III trials. The drug has been included as a Class I recommendation by the Chinese Society of Clinical Oncology guidelines and received orphan drug designation from the US FDA for both HER2-negative breast cancer brain metastasis and gastric cancer indications. Multiple expansion studies are ongoing globally including US-based trials.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (notably microtubule inhibitors via microbial fermentation)Nano-formulationsOral capsulesAntibody-drug conjugates in development
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Actively seeking partners; no major partnerships disclosed yet but open to business development inquiries.
Beyond the preview
Go deeper on Biostar Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biostar Pharmaceuticals.